Impact of a geriatric emergency management nurse on thirty-day emergency department revisits: a retrospective propensity score matched case-control study

Abstract

Background and Objectives: Geriatric Emergency Management (GEM) nurses aim to reduce adverse outcomes by addressing unique needs of older adults seen in emergency departments (EDs), but evidence to demonstrate their impact on ED care transitions is mixed. We evaluated the impact of implementing a GEM nurse model in a local ED on thirty-day revisits using propensity score matching to control for relevant patient characteristics. Research Design and Methods: A retrospective case-control design was used to analyze older adult patients who were triaged to a stretcher at an ED in Lévis, Québec, from October 2018 to September 2019. We used propensity score matching to compare patients who received the GEM nurse intervention with control patients who did not receive the intervention. This intervention involved a targeted geriatric ED assessment including history, physical exam, chart review, communication with caregivers and home care services, and the creation of an intervention and care transition plan to support safe discharge from the ED. Results: Out of 21,024 patients visiting the ED over a one-year period, 7,952 were eligible for analysis, with pre-matching differences showing GEM patients were older and more frequent ED users. Propensity score matching resulted in 724 patients with no significant differences in baseline characteristics between groups. Using a Cox regression analysis, we found a non-significant 6% decrease in the risk of ED revisit within 30 days for the GEM group (HR = 0.94, p = .692). Discussion and Implications: The GEM nursing intervention targeting better care transition plans personalized to the needs of each patient did not significantly impact thirty-day revisits to the ED. Further work is needed to determine the most effective specific components of such interventions to maximize future positive impact on the care transitions of older patients.

Competing Interest Statement

The authors have declared no competing interest.

Clinical Trial

NCT04093245

Clinical Protocols

https://clinicaltrials.gov/study/NCT04093245

Funding Statement

The LEARNING WISDOM clinical trial was funded by an Embedded Clinician Salary Award (ECRA) awarded to PMA from the Canadian Institutes for Health Research (CIHR) (#201603), a Fonds de recherche du Québec - Santé (FRQS) Senior Clinical Scholar Award (#283211), and a CIHR Project Grant (#378616). Work on this article was supported by a Master's Award: Canada Graduate Scholarships Award (CIHR) awarded to NG (#202112). The funding bodies had no role in the design of the study, collection, or analysis of the data, interpretation of the results, or writing of the manuscript. The authors do not have any conflicts of interest to declare.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

The protocol for this study was approved by the Centre intégré de santé et de services sociaux - Chaudière Appalaches (CISSS-CA, Québec, Canada) Ethics Review Committee (project #2018-462, 2018-007).

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

Data Availability

All anonymized data produced in the present study are available upon reasonable request to the authors.

留言 (0)

沒有登入
gif